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OBJECTIVES We conducted this study to determine the result of prolonged cardiopulmonary resuscitation
(CPR) with extracorporeal membrane oxygenation (ECMO) and the predictive factors for
hospital discharge and ECMO weaning.
BACKGROUND Prolonged CPR carries considerable associated mortality and morbidity. As yet, ECMO for
prolonged CPR has no definite results. Only small groups of patients and no detailed analysis
have been reported.
METHODS Candidates for ECMO resuscitation were patients in cardiac arrest receiving CPR 10 min
without return of spontaneous circulation and no absolute contraindication. Venoarterial
ECMO was set up during CPR. We reviewed the data of 57 prolonged CPR patients who
received ECMO during CPR over a six-year period.
RESULTS The mean duration of CPR was 47.6 13.4 min and that of ECMO was 96.1 87.9 h. The
rate of weaning was 66.7%, and the survival rate was 31.6%. Multiple-organ failure was the
major reason for mortality, despite successful weaning. Among survivors, long-term follow-up
revealed 88.9% survival, and only 5.6% had a severe neurologic deficit. The results indicate
that a shorter CPR duration, postcardiotomy arrest, myocardial indicators, a hepatic
indicator, and lactic acid are significantly correlated with both weaning and survival, whereas
late damage (level on the third or seventh day of reperfusion) rather than initial damage (level
on the first day) was more predictive of the results.
CONCLUSIONS Prolonged CPR rescue by ECMO provides an acceptable survival rate and outcome in
survivors. Our results of the selected cases encourage further investigations of the wider
application of ECMO in CPR. (J Am Coll Cardiol 2003;41:197–203) © 2003 by the
American College of Cardiology Foundation
Cardiopulmonary resuscitation (CPR) with closed-chest
cardiac massage, which was first introduced in 1960 (1), was
developed to maintain circulation and ventilation until
life-threatening problems could be corrected or reversed.
Studies on the effect of CPR have shown that survival to
discharge after CPR ranged from 8.2% to 22% among all
hospitalized patients and from 6% to 11% among critically
ill patients (2–5). Furthermore, the chances of survival
decline rapidly if the CPR period lasts 10 to 15 min
(6–8).
Because of the low survival rate after prolonged CPR,
more aggressive methods have been suggested to increase
success. Gibbon introduced cardiopulmonary bypass (CPB)
by means of thoracotomy and subsequently extracorporeal
venoarterial pumping and oxygenation (9). The use of CPB
and its extension to prolong circulatory support without
thoracotomy have been reviewed (10). With the advance-
ment of techniques, extracorporeal mechanical support has
been applied in conjunction with CPR, with variable results
(11–13).
Extensive animal data and preliminary clinical reports
suggest that extracorporeal mechanical support might be a
superior means of resuscitating some victims of cardiac
arrest (11–17). We have developed extracorporeal mem-
brane oxygenation (ECMO) during CPR (in brief, called
ECPR) since 1994. This study represents a six-year expe-
rience with ECPR at a single institution, in which we tried
to analyze risk factors influencing patient survival and
weaning from ECPR.
METHODS
Exclusion and inclusion criteria. Because ECPR is an
extremely expensive and aggressively invasive intervention
in considerable demand and with an unknown effect, we
usually selected patients whose condition leading to CPR
was thought to be of a cardiac origin. A brief and quick
evaluation was performed during CPR to preclude ECMO
contraindications, including previous irreversible brain
damage, terminal malignancy, and age 75 years. Those
who could not be weaned off CPB after surgery due to
postcardiotomy shock and were then shifted to ECMO
were not included in this study. Patients who experienced
progressive deterioration and needed ECMO support ur-
gently without cardiac massage or boluses of epinephrine
were excluded, as well.
Briefly, patients were recruited into the ECPR group only
if they: 1) were in cardiac arrest that necessitated external or
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open-chest cardiac massage and a large amount of epineph-
rine (5 mg) during CPR; 2) could not be returned to
spontaneous circulation within 10 to 20 min; and 3)
subsequently received ECMO in the hospital. Because of
the emergency status, oral permission was obtained first,
and formal consent was signed later after the ECMO setup.
ECMO circuit and equipment. The circuit and manage-
ment of ECMO have been described previously (18). The
circuit for ECPR is composed of a heparin-bonded Car-
meda Bioactive Surface circuit, a Maxima Plus PRF hollow-
membrane oxygenator with an integral heat exchanger, and
a Biopump centrifugal blood pump (Medtronic Inc., Ana-
heim, California). We did not have the bridging tube
between the arterial and venous lines for conserving man-
power. The bridging tube was reconnected to the circuit
when weaning was tried.
ECMO management. All circuits were primed with nor-
mal saline and heparin (2 U/ml) due to the emergent
condition. The warmer was connected to the circuit to
rewarm the patients up to 37°C gradually. Femoral cannu-
lation was preferred. For distal limb perfusion, we applied
the previously reported salvage method (19,20) of an an-
terograde reperfusion catheter to the distal artery. Trans-
thoracic cannulation was reserved for those necessitating
open-chest cardiac massage in postcardiotomy CPR. Hep-
arin (100 U/kg) was given to the patient immediately before
cannulation.
The pump flow started initially at 50 to 100 ml/kg per
min, with adjustment of vasopressors to maintain a mean
blood pressure of around 60 mm Hg. Low-dose heparin was
infused to keep the activated clotting time around 160 to
180 s. The high dose of catecholamine was tapered slowly.
If the myocardium was found to improve by echocardiog-
raphy, weaning from ECMO was tried. The activated
clotting time was adjusted to 220 s during the period of
weaning.
General management. EVALUATION OF CONSCIOUS-
NESS. The consciousness level had to be evaluated every
12 h after CPR. Cessation of ECMO was considered if a
severe neurologic insult persisted for more than seven days
without signs of recovery. Temporarily dilated pupils after
CPR or a bolus of epinephrine are usually found, and it
should not be considered an indication for withdrawing
ECMO within the first 24 h.
FURTHER INTERVENTION AND WEANING. The cause lead-
ing to CPR was investigated after spontaneous circulation
had returned, and treatment for the underlying cause was
started as soon as possible. It is important to perform
follow-up echocardiography every day to estimate the re-
covery of the heart and to detect possible thrombus forma-
tion in the left ventricle. A pulsatile arterial waveform
should be maintained by adjusting the catecholamine to
prevent left ventricular thrombus formation. Weaning
should not be tried until 72 h later. If a pulsatile arterial
waveform could be detected under dopamine and dobut-
amine (10 g/kg per min) and milrinone (0.5 g/kg per
min), a trial weaning was performed by gradually decreasing
pump flow. If the catecholamine dose had to be increased to
more than the aforementioned dose during weaning, the
trial weaning was discontinued and then restarted the next
day. If weaning was unsuccessful in four to five days, a
ventricular assist device or heart transplantation was con-
sidered in the absence of contraindications.
Data collection and statistics. Our collected data (Table
1) were modified according to the guidelines for reviewing
and reporting in-hospital resuscitations (21). The data are
shown as the mean value  SD (standard deviation), unless
specified otherwise.
In ECMO-supported patients, two resulting compari-
sons were of concern: 1) ECMO weaning versus non-
weaning and 2) survival-to-discharge versus in-hospital
death. Successful weaning was defined as weaning from
ECMO followed by survival beyond 48 h. Those who could
be weaned from ECMO but who died within 48 h were
defined as unsuccessfully weaned. Survival was defined as
weaning from ECMO followed by discharge from the
hospital. We attempted to identify the risk factors that
affected weaning and survival, and we analyzed the effect of
ECPR on survival.
Categorical variables were compared by using the Fisher
exact test. Continuous variables were compared by the
Mann-Whitney U test or Kruskal-Wallis test if there were
more than two groups. Spearman correlation was used to
pre-select the laboratory variables that correlated signifi-
cantly with the binomial variables of ECMO weaning or
hospital survival. We then applied these variables to the
simple logistic regression models on the predicted probabil-
ity of ECMO weaning and hospital survival. In these
regression models with given predicted probabilities of 0.1,
0.5, and 0.9, we then solved for the corresponding variable
values. (Logistic regression model: ln[p/(1 p)] 0 1
 X1; for p  0.1, 0.5, and 0.9, we solved for X1  [ln(p/[1
 p])  0]/1.)
Standard errors of these corresponding variable values
were estimated by the delta method (22). A p value 0.05
was regarded as statistically significant.
Stata 7.0 (Stata Corp., Texas) was used for statistical
analyses of this study. Microsoft Excel 2000 spreadsheets
Abbreviations and Acronyms
ACLS  advanced cardiopulmonary life support
AST  aspartate aminotransferase
CK(-MB)  creatine kinase (MB fraction)
CPB  cardiopulmonary bypass
CPR  cardiopulmonary resuscitation
Cre  creatinine
ECMO  extracorporeal membrane oxygenation
ECPR  ECMO during CPR
LA  lactic acid
VF  ventricular fibrillation
VT  ventricular tachycardia
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were used for the calculation of values for predicted prob-
abilities, by solving logistic regression equations, and stan-
dard errors by the delta method.
RESULTS
Characteristics of patients. A total of 57 patients (34 men;
57.1  15.6 years old) were resuscitated by ECMO in
conjunction with CPR. All received ECMO during cardiac
massage. Six patients (10.5%) had previous CPR before
ECPR. Only two patients (3.5%) received transthoracic
cannulation during ECPR. Twenty-seven patients (47.4%)
received a subsequent operation after ECPR. Fourteen
patients (24.6%) had postcardiotomy ECPR, and five
(35.7%) received a second operation to correct the under-
lying cause.
The duration of ECMO was 96.1  87.9 h, and the
interval between CPR and initiation of ECMO (CPR
duration) was 47.6 13.4 min. The successful weaning rate
was 66.7% (38/57), and the survival rate was 31.6% (18/57).
About half (52.6% [n  20]) of those who were successfully
weaned died later due to a severe neurologic deficit (10%
[2/20]), persistent cardiac failure (10% [2/20]), or multiple
organ failure (80% [16/20]). Among the survivors, only one
(5.6%) had a severe neurologic deficit due to prolonged
CPR (1 h).
One patient failed to be cannulated; this patient devel-
oped a massive retroperitoneal hematoma when percutane-
ous femoral cannulation was attempted. Three patients
(5.3%) were unable to return to spontaneous rhythm,
despite successful execution of ECMO.
ECPR in postcardiotomy arrest. Patients with postcar-
diotomy ECPR (n  14) had a significantly better survival
rate than those without postcardiotomy ECPR (57.14% vs.
23.26%, p  0.025). However, the postcardiotomy group
did not have a significantly higher weaning rate than the
non-postcardiotomy group (60.47% vs. 66.67%, p 0.109).
Duration of CPR. No patient received ECMO within 15
min after arrest and CPR occurred. The rates of weaning
and survival at different CPR durations are shown in Table
2. The data revealed that patients who were successfully
weaned experienced a shorter CPR duration (45.0  13.4
min in weaned patients vs. 52.9  11.6 min in non-weaned
patients, p  0.027). Survivors also had a much shorter
CPR duration (39.2 13.7 min in survivors vs. 51.5 11.3
min in non-survivors, p  0.0014). As seen in Table 2, the
survival rate was higher for CPR lasting 60 min than for
CPR lasting 60 min (p  0.004), and similarly, a higher
weaning rate was associated with a duration 60 min
(80.7% vs. 50%, p  0.023). The survival rate for CPR
lasting 45 min was also noted to be better than that for
CPR lasting 45 min (57.1% vs. 23.3%, p  0.025), but
not the weaning rate (78.6% vs. 62.8%, p 0.343). We also
could not demonstrate the statistic difference in both sur-
vival and weaning rate between those with CPR lasting45
min and those with CPR lasting 60 min. Therefore, we
could conclude that CPR 60 min followed by ECMO
rescue could predict a survival rate of around 50% and a
successful weaning rate of 80%, and the shorter the dura-
tion, the better the survival.
Subsequent interventions. A total of 32 subsequent inter-
vention procedures were performed in 28 patients receiving
ECPR in this study, including 12 coronary artery bypass
graft surgeries, two coronary angioplasties, three repairs of
ventricular rupture, two pulmonary embolectomies, one
creation of a fenestrated atrial septal defect, one replacement
of a thrombosed mechanical valve, one reconstructed ste-
notic aorta, six conversions to a ventricular assist device, and
four heart transplantations. Both the weaning rate (77.8%
vs. 56.7% with vs. without intervention) and the survival
Table 1. Data Reviewed
Demographics
Age
Weight
Gender
Underlying disease
Comorbidity: DM, hypertension
Previous heart surgery: yes/no
CPR
Witnessed
Monitored
Location: ICU/OR, catheterization laboratory, ward, out-of-
hospital
Previous CPR: yes/no
Event variables
Initial rhythm: VF, VT, asystole, PEA
Resuscitation attempted: chest massage, defibrillation
Interval between CPR and ECMO (CPR duration)
ECMO duration
Subsequent procedure: yes/no
Biochemistry data: BUN, creatinine, CK, CK-MB, troponin,
hemoglobin, platelets, white count, AST, INR on days 1, 3, 7,
and 10
Outcome variables
Return of spontaneous rhythm: yes/no
Weaned off ECMO: yes/no
Discharge from hospital: yes/no
Cause of death: brain, multiple-organ failure
Neurologic outcome: no significant defect, mild defect, severe defect
AST  aspartate aminotransferase; BUN  blood urea nitrogen; CK  creatinine
kinase; CK-MB  creatinine kinase-MB fraction; CPR  cardiopulmonary resus-
citation; DM  diabetes mellitus; ECMO  extracorporeal membrane oxygenation;
ICU  intensive care unit; INR  international normalized ratio; OR  operating
room; PEA  pulseless electric activity; VT  ventricular tachycardia; VF 
ventricular fibrillation.
Table 2. Relationship Between Weaning or Survival and CPR
Duration
CPR
Duration n %
Weaning
n (%)
Survival
n (%)
15 min 0 0
30 min 2 3.5 2 (100%) 2 (100%)
45 min 14 24.56 11 (78.57%) 8 (57.14%)†
60 min 31 54.39 25 (80.65%)* 15 (48.39%)*
60 min 26 46.61 13 (50%) 3 (11.5%)
Total 57 100 38 (66.7%) 18 (31.6%)
*p  0.05 compared with CPR 60 min. †p  0.05 compared with CPR 45 min.
CPR  cardiopulmonary resuscitation.
199JACC Vol. 41, No. 2, 2003 Chen et al.
January 15, 2003:197–203 Prolonged CPR With ECMO
rate (37.0% vs. 26.7%) were higher in patients with subse-
quent interventions, but the differences did not reach
statistical significance (p  0.159 for weaning, and p 
0.569 for survival). The CPR duration was still an impor-
tant factor influencing survival in the subgroup with subse-
quent interventions (36.0 12.6 min in survivors vs. 48.3
12.2 min in non-survivors, p  0.05). In patients with
non-postcardiotomy ECPR (n 43), the weaning rates did
not differ significantly between those with and those with-
out subsequent procedures (72.73% vs. 47.62%, p  0.124).
Also, there was a borderline difference in survival rates
(33.36% vs. 9.52%, p  0.069) in those with and those
without subsequent procedures.
Initial rhythm, defibrillation, and witnessed and moni-
tored cardiac arrest. Almost all patients (96.5%) received
initial CPR in the hospital; a witnessed arrest occurred in
96.5% of patients; and 84.2% of patients were monitored
during CPR. Ventricular fibrillation (VF) was noted in 27
patients (47.4%), ventricular tachycardia (VT) in eight
patients (14.0%), and arrest and pulseless electrical activity
in 22 patients (38.6%). In all patients, defibrillation had
been tried before ECMO. These four factors did not affect
the outcome in terms of weaning and survival (p  0.05).
However, we discovered that the use of ECMO in pro-
longed CPR resulted in a very high incidence of return to
spontaneous rhythm (94.7%).
Previous CPR. Six patients (10.5%) had a previous CPR
before the episode of ECPR, but the previous CPR did not
influence the weaning or survival rate for either the whole
group or the non-postcardiotomy group (p  0.05).
Duration of ECMO. There was no significant difference
in ECMO duration either in weaning (105.6  87.8 h in
weaning vs. 77.2  87.2 h in non-weaning, p  0.092) or
in survival (104.9  103.7 h in survivors vs. 92.0  80.8 h
in non-survivors, p  0.76). When focusing on the non-
postcardiotomy or postcardiotomy patients, ECMO dura-
tion did not affect weaning or survival in the subgroups (p
0.05).
Correlation of biochemistry with weaning or sur-
vival. Table 3 shows the correlation between biochemical
factors in weaning and survival. The weaned and non-
weaned groups differed significantly (p  0.05) by Spear-
man’s method with respect to creatinine on the third and
seventh days (Cre3, Cre7), aspartate aminotransferase
(AST) on the third day (AST3), creatine kinase (CK) on
the third day (CK3), creatine kinase, MB fraction (CK-
MB) on the third and seventh days (CK-MB3, CK-MB7),
and lactic acid (LA) on the third and seventh days (LA3,
LA7). When comparing survival and non-survival, Cre7,
AST3, AST7, CK1, CK3, CK7, CK-MB3, CK-MB7,
LA1, LA3, and LA7 showed a significant correlation with
survival (Table 3). From the analysis, the biochemistry data,
including Cre7, AST3, CK3, CK-MB3, CK-MB7, LA3,
and LA7, had correlations with both weaning and survival.
They could be regarded as predictive indicators for the
ECPR result.
Long-term follow-up. Eighteen patients survived to dis-
charge after ECPR. The mean duration of follow-up was
48.5  12.2 months (range 6 to 68). Only one patient
became vegetative with a severe neurologic deficit due to
prolonged CPR (60 min). Another patient, who was a
victim of postcardiotomy left ventricular rupture and re-
ceived 65 min CPR, had to have a limb amputated because
of ischemia due to ECMO cannulation and was discharged
Table 3. Analysis of the Factors in Weaning and Survival by the Spearman Method
Biochemical
Factors n
Weaning Survival
Corr. Cf. p Value Corr. Cf. p Value
CPRD 57 0.2860* 0.0254 0.4269* 0.0009
BUN1 56 0.0438 0.7486 0.1042 0.4449
BUN3 36 0.3176 0.0591 0.1002 0.5608
BUN7 18 0.3467 0.1587 0.2155 0.3904
Cre1 56 0.0071 0.9585 0.0355 0.7949
Cre3 36 0.4225* 0.0103 0.3119 0.0641
Cre7 18 0.5140* 0.0291 0.5387* 0.0211
AST1 55 0.0183 0.8945 0.0842 0.5410
AST3 34 0.4784* 0.0042 0.6526* 0.0000
AST7 16 0.4700 0.0662 0.7521* 0.0008
CK1 51 0.2719 0.0536 0.3122* 0.0257
CK3 34 0.4337* 0.0104 0.4203* 0.0133
CK7 15 0.4885 0.0647 0.5669* 0.0275
CK-MB1 51 0.1038 0.4685 0.2662 0.0590
CK-MB3 34 0.4004* 0.0189 0.4957* 0.0029
CK-MB7 15 0.5932* 0.0198 0.6614* 0.0072
LA1 54 0.0806 0.5624 0.3995* 0.0028
LA3 35 0.4431* 0.0077 0.4628* 0.0051
LA7 16 0.6585* 0.0055 0.7253* 0.0015
*p  0.05. The p values are two-tailed. The number after the factor abbreviations is the number of days of ECMO (e.g., BUN1
means the BUN level on the first day of ECMO).
Corr. Cf.  correlation coefficient; CPRD  cardiopulmonary resuscitation duration; Cre  creatinine; LA  lactic acid;
other abbreviations as in Table 1.
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with a clear consciousness. One patient with a pulmonary
embolism died two years later due to the underlying ovarian
malignancy, and the other patient receiving a heart trans-
plant had a sudden death four years later; chronic rejection
was suspected. Long-term follow-up of survivors was 88.9%
(16/18) in the discharge group and 28.1% in the ECPR
group.
DISCUSSION
Cardiopulmonary resuscitation has been widely used for
cardiac arrest since the introduction of closed-chest cardiac
massage. Several reports revealed only a 16% to 45% rate of
initial response to CPR, a lower survival-to-discharge rate
for in-hospital cardiac arrests (10% to 15%) (3,4,23,24), and
an even worse outcome for prolonged resuscitation (8,25).
Multi-institutional trials of emergency CPB also revealed
better survival than conventional CPR in the early 1990s
(12,16). However, no single study in the last 10 years has
analyzed the factors influencing weaning from ECPR and
the survival of ECPR patients.
Previous studies of CPR showed that a witnessed arrest
was associated with a favorable outcome in in-hospital
resuscitation (3,23). We examined the pre-CPR status, such
as witnessed or monitored arrests and different arrhythmias,
and our conclusion differed from the conclusion of previous
studies. The majority of the patients in this study received
initial CPR (96.5%) in the hospital, and most of them
(96.5%) had cardiac arrests that were witnessed. This might
be the reason that the statistic could not show a difference.
Unwitnessed arrests could have been excluded from the
study because of the relatively uncertain arrest time, but we
still included them (n 2) to complete the data for patients
treated with ECMO to rescue them from CPR.
Despite the fact that some reports revealed CPR in the
VT/VF group was associated with better survival than in the
non-VT/VF group (26), we could not draw a similar
conclusion from our ECPR data. We believe it was ECMO
that made the different result. The previously reported
incidence of sustained return of spontaneous rhythm due to
advanced cardiopulmonary life support (ACLS) (20.2% to
33.5%) (24,25) was considerably lower than that found in
this study (94.7%). Early return of spontaneous rhythm in
our group might contribute to active decompression of the
heart by ECMO and provide immediate circulatory support
to decrease progressive acidosis. Also, ECMO could protect
and preserve the myocardium through increased tissue
perfusion and provide better survival, regardless of different
initial rhythms.
In our study, no one started ECMO support within the
first 15 min of ACLS. This was because ACLS was tried
first to sustain a return of spontaneous circulation before
deciding to use ECMO, and it usually took more than 20
min to try ACLS and set up ECMO. Therefore, the
duration between CPR and ECMO in this ECPR study
was longer than that in any other previously reported series
with conventional CPR. The CPR duration in survivors was
39.2  13.7 min, which was significantly shorter than that
of non-survivors (51.5  11.3 min, p  0.0014). A similar
difference with less significance was found between weaned
and non-weaned patients (p 0.027). Our study confirmed
again that a shorter CPR duration correlated with shorter
weaning and better survival (Table 2). A recent study even
found that CPR 10 min correlated with a very high
mortality (80%) (8,27). In our study, 100% of those whose
CPR duration was 30 min were weaned from ECPR and
survived; in those receiving CPR 60 min, the survival rate
was acceptable, and the incidence of weaning was high.
From this study, we conclude that ECMO can extend the
CPR time to 60 min with an acceptable survival rate and an
acceptable neurologic result, which is the great benefit of
applying ECMO in CPR.
Our data revealed a significantly higher survival rate in
the postcardiotomy group (p  0.05). This was not related
to the different CPR duration between the two groups,
because the CPR duration of these two groups did not show
a significant difference (47.4 min in the postcardiotomy
group vs. 48.9 min in the non-postcardiotomy group, p 
0.05). Despite the fact that two patients in the postcar-
diotomy group had ventricular rupture with massive bleed-
ing, the postcardiotomy ECPR group still showed better
rates of weaning and survival. It might be argued that the
postcardiotomy group should not have been taken into the
study group, because it might represent a different group of
patients. However, the postcardiotomy patients included in
the study were not extending CPB after the operation due to
difficulty of weaning from CPB, but they were patients who
were weaned from CPB and collapsed later suddenly,
followed by ECPR. We therefore still took them into the
ECPR group.
Several possibilities for better survival in the postcar-
diotomy group might be speculated about: 1) they were
pre-selected by virtue of their preoperative screening and
expected to survive their original surgery in postcardiotomy
ECPR; 2) the detection of arrest in the postcardiotomy
ECPR patients was earlier because all the arrests happened
within 24 h postoperatively; and 3) the possible detrimental
factors or underlying anatomic factors had been corrected
before ECMO, so that the patients could be weaned from
CPB initially after surgery.
To our surprise, the subsequent interventional procedure
did not increase weaning or survival rates. Even in the
non-postcardiotomy group, subsequent interventional pro-
cedures did not reach statistical difference in weaning rates
(p  0.124), but they approached a statistical difference in
survival rates (p  0.069). This might be because the study
group included patients with various etiologies leading to
CPR and the sample size may not have been large enough
to show the difference. When focusing on subgroups with
an initial acute coronary syndrome (n  22), subsequent
intervention still did not play an important role in survival,
which was due to a limited patient volume.
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We tried to identify the factors correlated with weaning
or survival by comparing biochemical data before and during
ECMO support. Interestingly, myocardial function indica-
tors (e.g., CK-MB) still played a significant part in both
weaning and survival (p  0.05). The renal function
indicator (Cre) was also correlated to weaning (p  0.05 for
Cre3 and Cre7) and survival (p  0.05 for Cre7). This
finding confirmed the previous analysis study concerning
the survival of patients in the postcardiotomy group who
received ECMO (28,29). However, with the advancement
of supporting technology, injured myocardium and kidneys
can be easily supported by ECMO and hemofiltration.
Some selected patients could be converted from ECMO to
ventricular assist devices for long-term support and trans-
plantation.
Aspartate aminotransferase and LA had a good correla-
tion with weaning (p 0.05 for AST3, LA3, and LA7) and
survival (p  0.05 for AST3, AST7, LA1, and LA7). This
correlation reflects the fact that persistent hepatic damage
and slow reversibility of lactic acidosis are important in
weaning and survival. Initial indicators (Cre, CK, and
CK-MB on the first day) failed to show a good correlation
and predict the outcome, but the factors by the third and
seventh days of ECPR showed good correlation with
outcome. Those who are interested in the efficacy of ECPR
should take this finding into consideration. Not the initial
damage, but that occurring during reperfusion several days
later—especially on the third day—can predict survival.
This finding deserved further investigation to prevent reper-
fusion injury by ECMO after CPR.
From the data, we tried to identify the levels at which
different biochemical indicators might be used to predict
weaning and survival. Table 4 describes the predictive levels
of significant factors derived from Table 3 in different
probabilities of survival and weaning. The predictive level of
different factors shown in Table 4 was carefully calculated
only for those factors with both significant correlation
coefficients (p  0.05) (Table 3) and significant logistic
coefficients (1) (p  0.05) after logistic regression. There
might be an overlap between the 95% confidence interval in
some factors, and it may not be precise in predicting the
outcome; but these data still could help physicians make
rough predictions about survival or weaning from ECPR.
Only one surviving patient (5%) had a severe neurologic
deficit after prolonged CPR followed by ECMO rescue.
Although the neurologic outcome after conventional CPR
usually carries an acceptable incidence of neurologic insult
(23), the CPR duration of survivors was much less than that
of those receiving ECPR in our study; this difference must
be considered when comparing the results of our study with
results from others. We speculate that a rapid return of
circulation, immediate adequate support, and highly oxy-
genated blood to the brain by ECMO may be the key to
achieving good cerebral resuscitation results, even after
prolonged CPR. This is an important benefit supporting the
application of ECMO in selected CPR cases.
Study limitations. Our study of ECPR efficacy is not a
randomized, controlled study; and the pre-selection criteria
for ECPR usually considers only those without previous
cerebral injury who have had prolonged CPR and for whom
a better outcome may be expected. The case number is not
large, as well, so that only a few factors can be identified
with significant associations to weaning or survival. The
do-not-resuscitate policy may pre-select patients with a
better outcome for continuous CPR.
Moreover, ECPR is more expensive than conventional
CPR. The cost-effectiveness of ECPR deserves consider-
ation before application is instituted. From our data, less
neurologic defect was noted in survivors, which may be
related to the withdrawal of treatment if a significant
neurologic defect was found during ECPR.
Conclusions. Despite these limitations, our results reveal
that ECMO can be used with prolonged CPR and renders
acceptable survival with minimal neurologic insult in survi-
vors. This surgically aggressive ECPR is proven effective in
either the surgical or non-surgical group of patients. The
ECPR result deserves further, randomized study in some
groups of patients before a generalized application can be
formulated.
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Table 4. Predictive Levels for Different Probabilities of Weaning and Survival
Factors
Pp  0.1 Pp  0.5 Pp  0.9
Weaning Survival Weaning Survival Weaning Survival
CPRD 104  52 65  18 62  35 36  11 27  20 13  6
Cre3 7.4  3.7 — 5.0  2.8 — 2.6  2.1 —
AST3 — 381  188 — 177  116 — 30  87
CK1 — 6,978  3,591 — 609  1,165 — 160  3,032
CK3 57,030  23,272 — 32,202  15,097 — 7,375  9,424 —
LA1 — 20.8  9.0 — 7.6  5.3 — 0.3  5.0
LA3 13.7  6.6 6.6  3.1 9.2  4.9 3.0  2.0 4.8  3.6 0.2  1.6
Data are presented as the mean value  SE.
AST  aspartate aminotransferase (U/l); CK  creatinine kinase (U/l); CPRD  cardiopulmonary resuscitation duration (min); Cre  creatinine (mg/dl); LA  lactic acid
(mmol/l); Pp  predictive probability, as the probability p used in the ln(p/[1  p]) of logistic regression.
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